-
Bicinchoninic Acid Assay (BCA) Kit Guide
2026-09-11
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including many cell lysates and detergent-containing biochemical preparations. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.
-
BCA Protein Quantification Kit: K4102 Guide
2026-09-10
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides total-protein measurement for dilute biochemical samples, including many detergent-containing preparations and cell lysates. It is intended for research workflows and sample normalization, not diagnostic, clinical, or medical testing.
-
Sulfo-NHS-SS-Biotin for Spatial Protein Capture
2026-09-10
Sulfo-NHS-SS-Biotin combines amine-selective labeling with a reducible disulfide linker for reversible protein purification and surface proteomics. This guide explains how its chemistry complements, but does not replace, TurboID-based spatial interaction mapping in Notch research, with practical controls for choosing the right assay.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-09-09
This dossier-centered guide explains how to prepare, store, control, and interpret (+)-Bicuculline for experiments that test GABAA receptor-mediated inhibition and related neuronal signaling. It is a neuroscience research tool for controlled laboratory studies only and should not be used for diagnostic, clinical, or therapeutic purposes.
-
L-Ornithine in Urea Cycle and CNS Research
2026-09-09
L-Ornithine, also called (S)-2,5-diaminopentanoic acid, is a defined urea cycle intermediate for ammonia detoxification and amino acid metabolism research. Its documented OTC relationship makes it useful for metabolic enzyme assay design, while recent preclinical evidence connects disrupted ornithine regulation with astrocyte glycolysis in realgar-associated CNS toxicity.
-
MK-5108 (VX-689) Aurora A Assay Guide
2026-09-08
MK-5108 (VX-689) provides a highly selective way to connect Aurora-A kinase activity with cell-cycle arrest, tumor-cell growth, and retinoblastoma biology. This practical guide distinguishes biochemical potency from cellular response and outlines reproducible workflows for cancer cell line proliferation assays, cell-cycle analysis, and translational xenograft studies.
-
Bestatin as a Chemical Genetics Tool for Jasmonate Signaling
2026-09-08
The reference study shows that Bestatin can activate jasmonate-responsive processes in Arabidopsis and tomato through a COI1-dependent pathway, even when jasmonate biosynthesis is not strictly required. By combining gene-expression analysis, developmental phenotyping, and screening for bestatin-resistant mutants, the authors establish an inhibitor-based chemical genetics strategy for identifying regulators of plant jasmonate signaling.
-
ARL4C, Synoviocyte Proliferation, and RA Progression
2026-09-07
A study integrating single-cell and bulk transcriptomics identifies ARL4C as a regulator of aggressive fibroblast-like synoviocytes in rheumatoid arthritis. Perturbation experiments connect ARL4C with synoviocyte proliferation, invasion, macrophage polarization, and joint pathology in collagen-induced arthritis, while also highlighting opportunities and limitations for mechanism-focused validation.
-
SB525334: A Causal Tool for TGF-β1 Research
2026-09-07
Explore how SB525334, a selective TGF-beta1 receptor inhibitor, can distinguish TGF-β1 pathway association from causality across fibrosis, renal disease, and wound-healing assays. This guide translates mechanistic evidence into better experimental design and interpretation.
-
SB525334: TGF-β1 Signaling in Context
2026-09-05
SB525334 is a selective TGF-beta1 receptor inhibitor for dissecting ALK5-dependent signaling in fibrosis, renal disease, and wound-repair models. This article explains how to interpret pathway inhibition when TGF-β1 can be either pathogenic or reparative, using bone-transport research to refine assay design.
-
Amikacin (BAY416651) in Resistance Research
2026-09-04
Amikacin (BAY416651) is a semi-synthetic aminoglycoside antibiotic and bacterial protein synthesis inhibitor used in antibiotic resistance research. Its activity against the bacterial 30S ribosomal subunit and its relative resistance to many aminoglycoside-modifying enzymes make it useful for controlled studies of resistant Enterobacterales, while AAC (6′)-I-mediated modification remains an important limitation.
-
CNQX for AMPA/Kainate Circuit Mapping
2026-09-04
CNQX enables selective interrogation of AMPA and kainate receptor signaling without directly targeting NMDA receptors. This guide translates that pharmacology into practical workflows for synaptic physiology, circuit mapping, excitotoxicity research, and cardiovascular neurobiology.
-
WY-14643: PPARα Assay Workflows
2026-09-03
WY-14643 (Pirinixic Acid) enables controlled PPARα activation across lipid metabolism, endothelial inflammation, and translational oncology workflows. This practical guide covers dosing design, multiomics integration, solubility handling, and controls that help distinguish receptor-dependent biology from nonspecific metabolic effects.
-
Sabutoclax: From Target Binding to Cell Death
2026-09-03
Sabutoclax is a pan-Bcl-2 inhibitor whose target profile makes it useful for dissecting apoptosis induction in cancer cells. This article presents a response-phenotyping framework that separates cytostasis from cell killing and translates molecular binding data into better assay decisions.
-
SB525334: TGF-beta1 Receptor Inhibitor Workflows
2026-09-02
SB525334 provides a receptor-proximal way to test how ALK5-dependent TGF-β signaling drives fibrosis, renal injury, and wound-repair phenotypes. This practical guide connects Smad2/3 phosphorylation inhibition with the angiogenic and osteo-immune findings of a diabetic foot ulcer study, while separating validated evidence from assay-development recommendations.